Drug Eluting Balloon Catheter Market in Europe to Remain Highly Attractive

Drug eluting balloons (DEB), one of the newest medical devices, have become popular as it is used for treating coronary artery diseases. In addition, patients who find difficult to undergo percutaneous coronary intervention (PCI) procedures opt for drug eluting balloon catheter. Consequently, drug eluting balloon catheter manufacturers have upped their production capacity. In a bid to expand its market penetration, companies vie to manufacture cost-effective catheters. Rising cases of cardiology intervention and rampant cardiovascular diseases have further signified the importance of drug eluting balloon catheter.

The emergence of new-generation drug eluting balloon catheters have opened avenue for stakeholders and manufacturers in the market. Moreover, in order to accentuate its utility, massive investments in research and development pipelines have been witnessed. Growing number of companies are gradually shifting towards manufacturing drug eluting balloon catheters as it has turned out be viable and efficient vis-à-vis balloon angioplasty or stenting.

Request Sample Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=146

A lately compiled research analysis on the drug eluting balloon catheter market unveil that ever-increasing healthcare expenditure, burgeoning geriatric demographic, enhanced reimbursement support by governments will account for the augmentation of the drug eluting balloon catheter.

However, DEB do face daunting challenge rom drug eluting stents (DES) for the treatment of coronary artery disease. Though clinical application of drug eluting stents has significantly lessened the incidence of in-stent restenosis, delayed stent thrombosis and malapposition does not augur fare well with DES. On account of complications associated with DES, drug eluting balloon catheter was designed to negate insertion of a permanent foreign object in the blood vessel.

By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.

By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market. By 2022-end, the hospital segment is expected to reach a market valuation of over US$ 333 Mn.

Drug Eluting Balloon Catheter Market: Overview

The report provides an exhaustive analysis on the market for drug eluting balloon catheter for the assessment period 2018-2026. The report further sheds light on the dynamics of the drug eluting balloon catheter market which significantly impact the growth of the market.

Furthermore, the report delves into the segregation of the market which is will provide readers with an actionable insights which will aid them in taking proper decision based on segments historical and future growth estimates.

Browse Full Report with TOC:

https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market

The report also focuses on the epidemiology and product mapping behavior on the basis of region. The report also incorporates average pricing analysis and sheds light on supply chain. Assessment of the drug eluting balloon catheter market incorporates provision of relevant market numbers and regional assessment of major factors. The report also includes regional and country-wise assessment.

A robust research methodology has been adopted for the forecast and assessment on the drug eluting balloon catheter market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The market size of the drug eluting balloon catheter is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.

Drug Eluting Balloon Catheter Market: Competitive Landscape

Prominent market players being instrumental in the growth of the drug eluting balloon catheter market are profiled and assessed on the basis of company overview, financial overview, product offering, recent development, key differentiators and strategies. The report also includes SWOT analysis as well as gives insights on drug eluting balloon catheter market indication list and the drug eluting balloon catheter market indication sales data and key financials.

Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corporation, Terumo Corporation, Boston Scientific Corporation, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, and Medtronic Plc. are the leading companies profiled in Fact.MR’s report.

Analysis of the major market players becomes indispensable as it will succor readers to make proper decision to enlarge their business and can comprehend strategic moves made by prominent players in the drug eluting balloon catheter market

Antibodies Market: Adoption of Protein Therapeutics Underpins the Growth

One mode through which immune system latches onto foreign substances is by constructing massive numbers of antibodies. Antibodies hover around the body until they spot the antigen; once attached—they can engage other parts of the immune system to decimate the antigen containing cells.

Soaring incidence of chronic diseases such as cancer, diabetes and autoimmune conditions have acted as catalysts to drug makers to further augment antibody-based products. Consequently, research and development activities concerning antibodies has exponentially propped up in the past few decades. Meanwhile, the U.S. Food and Drug Administration (FDA) has given consent to more than a dozen mAbs to treat certain cancers. In addition, soaring acceptance of protein therapeutics along with ubiquity of epidemic diseases is having a sanguine impact on the sale of antibody-based products. However, one of the underlying problems is the prevalence of alternative therapeutics which does not augur well with the development of antibodies in global scale. Besides, high cost and side effects pertaining to antibodies further act as impediment to the sale of antibodies-based drug.

Currently, North America dominates the global antibodies market in terms of revenue and trend is projected continue in 2017 and beyond. In addition, the market in the region is expected to increase at a moderate CAGR during the forecast period (2017-2022). Presence of leading market players and existence of a well-established healthcare infrastructure is supporting the growth of the market in the region.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=194

As B lymphocytes or B cells are pivotal in the production of antibodies, combined together they offer indispensable function of immunity. Offering a basis for the augmentation of therapeutic antibodies and for vaccine development turns out to be pivotal incentive for measuring antibody function.

Antibodies Market: Overview

The report moots a comprehensive analysis on the market for antibodies for the assessment period 2018-2026. The report also delves into the dynamics surrounding the antibodies which significantly influence the growth of the Antibodies Market.

Furthermore, the report elucidates the segregation of the market which is anticipated to provide readers with an actionable insights which will aid them in taking proper decision based on segments historical and future growth estimates.

Browse Full Report with ToC Here: 

https://www.factmr.com/report/194/antibodies-market

The report focuses on cost structure and supply chain to provide a holistic view of the antibodies market. The report provides a coherent assessment through average pricing analysis. The report also includes regional and country-wise assessment.

A qualitative and quantitative information has been obtained for the forecast and assessment on the antibodies market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The growth of end use industries in the historical and forecast period have been estimated to aid the readers with their business investment decisions. The market size of the antibodies is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.

Antibodies Market: Competitive Landscape

Major market players being instrumental for the growth of the antibodies market are profiled and assessed on the basis of company overview, financial overview, product offering, recent development, key differentiators and strategies. The report also includes SWOT analysis to provide a holistic picture of the competitive scenario of the antibodies market. A deep dive analysis of the major market players becomes indispensable as it will succor readers to make proper decision to enlarge their business and can comprehend strategic moves made by prominent players in the antibodies market.

The report has also profiled key players operating in the global antibodies market, which include Abcam Plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Genscript Biotech Corporation, Sigma Aldrich Corp, Crown Bioscience, Inc., Thermo Fisher Scientific, Inc.

Vaccine Delivery Devices Market: Syringes to Represent a Leading Segment

 Pervasiveness of infections and diseases such as hepatitis A, hepatitis B, meningitis, and influenza has hard-pressed the drug manufacturers to develop vaccines to cure these conditions. Growing needs for the treatment of medical conditions have boosted the growth of the global vaccine delivery devices market.

Unhealthy food habits and consumption of sugar in large quantities have resulted in the rising instances of diabetes type 1 and diabetes type 2. Genetics and age also play a pivotal role in the rising glucose level in a human body. In order to control the blood sugar level, medical practitioners have been recommending Novorapid and Lantus as insulin, which has spurred the demand for these devices.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=178

Widespread adoption of needle-free devices for injecting a dose painlessly is witnessed in the medical field. A host of these factors have contributed to the robust growth of the vaccine delivery devices market, which is anticipated to record a healthy CAGR through 2022, according to a report issued by Fact.MR.

Vaccine Delivery Devices Market: Scope of the Report

The primary focus of this descriptive study on vaccine delivery devices is to lend a decisive view of the market to the stakeholders. The prediction has been done for the period from 2017 to 2022, wherein 2017 is considered as the base year and forecast has been offered for the duration 2018 to 2022. The market evaluation has been done in revenue (US$ Mn).

Browse Full Report with ToC Here:  https://www.factmr.com/report/178/vaccine-delivery-devices-market

The report commences with a detailed executive summary, which delineates the scope of the study. An incisive analysis of the year-over-year growth is included in this market study, in order to offer in-depth information on the growth patterns of the market. In the next section of the study, several macroeconomic and microeconomic factors influencing market growth has been discussed and listed. The report describes the demand drivers, opportunities, threats, restraints and challenging, affecting the market growth at the global level. Market segmentation has been included in the report, in the bid to lend a holistic view of the market to the stakeholders.

An in-depth analysis of the supply chain and average pricing is incorporated in the report to understand the dynamics of the vaccine delivery devices market. Evaluation of the attractiveness of the market has been carried out depending on the region, route of administration, and product type.

Region-wise Analysis of the Vaccine Delivery Devices Market

On the basis of the geographies, the report includes an analysis of Latin America, North America, Japan, Europe, Asia Pacific except Japan (APEJ), and the Middle East and Africa (MEA). An incisive view of the market is included in the report which sheds light on the market size, market value, and recent developments. According to the report, Asia Pacific is considered the fastest growing market at the global level, while North America is foreseen to remain the dominant market at the global level.

An Abstract of Competition Prevailing in the Vaccine Delivery Devices Market

The competitors in the vaccine delivery devices market comprise of Becton Dickinson & Company, PharmaJet, Inc, Vaxxas Pty. Ltd, Schott AG, Valeritas Holdings, Inc, Gerresheimer AG, Antares Pharma, Inc., and 3M Company. The report incorporates a comprehensive overview of the company, their business strategies, market size, and recent developments.

Peptide Based Cancer Therapeutics Market To Surpass A Valuation of US$ 11,100 Mn Over 2022

According to a report published by Fact.MR, the global peptide based cancer therapeutics market is poised to surpass the market valuation of US$ 11,000 Mn by the end of 2022, owing to multiple factors contributing to this boom.

Medical institutions across the world are ramping up their efforts towards the development of effective therapeutic drugs for cancer treatment. In addition to this, investors are underpinning the initiatives of healthcare organizations by funding their researches. With the report produced by the World Health Organization (WHO) stating the occurrence of over 8 Mn deaths in 2015 backed by the pervasiveness of cancer, proliferating adoption of advanced peptide based cancer therapeutic is witnessed. A host of these factors have contributed to the growing size of the peptide-based cancer therapeutics market at the global level with an estimated CAGR of over 9% through 2022.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=179

North America enjoys a large concentration of peptide based cancer therapeutic drug manufacturers, which has reflected positively on the growth of this market. Additionally, the advanced healthcare infrastructures have also been a driving factor fostering the growth of this market.

On the basis of drugs, the bortezomib segment is expected to remain highly attractive throughout the assessment period. The segment currently accounts for around 40% revenue share of the global market. Between 2017 and 2022, the segment is expected to reflect a double-digit CAGR to reach a valuation is excess of US$ 4,725 Mn. It expected to grow at US$ 358.4 Mn annually over the course of the forecast period.

Peptide Based Cancer Therapeutics Market: Synopsis of the Report

The primary aim of this market study on peptide-based cancer therapeutics is to lend a holistic view of the market to the stakeholders. The forecast has been done for the period from 2017 to 2022. Here, 2017 is considered as the base year and prediction has been provided for the duration 2018 to 2022. The market evaluation has been done in revenue (US$ Mn).

The report commences with a detailed executive summary, which further provides the scope of the study. An analysis of the year-over-year growth is incorporated in the study, with a view to providing information on the growth patterns of the market. In the succeeding section of the report, macroeconomic and microeconomic factors influencing the market growth has been discussed and included. The report delineates demand drivers, opportunities, threats, restraints and challenging, impacting the market at the global level. A segment-wise analysis is also included in the report, in order to lend a decisive view of the market to the stakeholders.

Browse Full Report with ToC Here: 

https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market

An analysis of the supply chain and average pricing is discussed in the report to understand the dynamics of the peptide-based cancer therapeutics market. Evaluation of the attractiveness of the market has been carried out on the basis of region, drug, and distribution channel.

Outline of Dominant Competitors and Geographies Influencing the Growth of the Peptide-based Cancer Therapeutics Market

The regions analyzed in the report consist of Latin America, North America, Europe, Japan, Asia Pacific except Japan (APEJ), and the Middle East and Africa (MEA). The regions have been analyzed keeping the segments – drug and distribution channel and their revenue share to the global market in mind.

The leading companies profiled in this market study includes Allergan plc, Valeant Pharmaceuticals International, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Johnson & Johnson, and Abbott, Pfizer Inc. An in-depth company overview, business strategies, market size, and recent developments are discussed in this report. These insights incorporated in the report will aid the drug manufacturers, raw material distributors, and research institutes in devising informed strategies to capture a large market share.

コメント

 

 

 

 

• 
• 
• 
• 

Gas Chromatography Market: Oil & Gas Industries Will Continue to be the Largest End-Users

According to a new report by Fact.MR, the global gas chromatography market will register an above-average growth during the forecast period (2017-2022). Revenues from the global gas chromatography market are anticipated to surpass US$ 3,500 Mn by 2022-end.

Gas chromatography has witnessed a significant surge in adoption in recent years across various industry verticals including healthcare, food & beverage, agriculture, and oil & gas. Application of gas chromatography has witnessed a widening scope, in combination with mass spectrometry, which range from fire investigation and environmental analysis, to detection of drugs and examination of explosives.

While governments worldwide are making investments dedicated to advancements in chromatography technologies, there has been a rise in collaboration activities between academic institutes and research laboratories. As gas chromatography tests become increasingly vital in drug developments and testing procedures, their demand will continue to remain robust in the pharmaceutical and biotechnology industries.

Get Free Sample Report Here https://www.factmr.com/connectus/sample?flag=S&rep_id=193

Improving economic conditions in emerging countries, along with government efforts in improving healthcare infrastructure and facilities, are some of the macroeconomic factors that continue to influence growth of the gas chromatography market. Key players in the gas chromatography market have been shifting their focus toward compact equipment and instruments, to save on space and investments alike. Rising adoption of micro gas chromatographs is another factor fuelling expansion of the gas chromatography market, which can be attributed to greater reliability, accuracy & precision, reduced delayed in receiving results, and lower energy consumption of micro gas chromatographs.

Gas Chromatography Market: Report Summary

This report analyzes the gas chromatography market, and offers accurate forecast for the period between 2017 and 2022. Readers of this report can find a precise and unbiased analysis on key trends, and dynamics that pose significant impact on growth of the gas chromatography market. This report can benefit various sectors associated with the gas chromatography market, such as raw material suppliers, research institutes, and medical device manufacturers.

Browse Full Report with ToC Here: 

https://www.factmr.com/report/193/gas-chromatography-market

The report commences with an executive summary that highlights leading segments and their share in the gas chromatography market, along with information on the global market's value in 2017. The next section offers a concise introduction to the gas chromatography market, along with an accurate definition of the target research area - "gas chromatography." Succeeding chapters of the report emphasize key market drivers, restraints, opportunities and trends that continues to influence expansion of the gas chromatography market.

A segmental analysis has been offered for the gas chromatography to offer readers with a comprehensive view of the growth prospects at current as well as in the near future. The report also covers an in-depth assessment on the gas chromatography market's competition landscape, and key players operating in the market have been profiled in detail.

North America will retain its dominance in the global gas chromatography market, with sales exhibiting an impressive expansion through 2022. United States is becoming well known for its biopharmaceutical research, and the production of pharmaceutical drugs. Geriatric population in North America has been surging, which in turn is driving demand for medicines to treat various diseases. These factors will propel growth of the market in North Americ. Europe will continue to be the second largest market for gas chromatography throughout the forecast period.

Gas Chromatography Market: Research Methodology

A robust research methodology backs the insights and analysis offered on the gas chromatography market in this report. This research methodology is a perfect blend of comprehensive primary and secondary researches. Information gained by the primary research is used for validating the insights obtained from secondary researches.

Key market players listed in Fact.MR’s report include Agilent Technologies, DANI Instruments S.p.A, Thermo Fisher Scientific, Inc., Merck KGaA, Restek Corporation, Shimadzu Corporation, LECO Corporation, Perkin Elmer Inc., and Danaher Corporation.

This report aims at providing authentic and credible insights to readers, along with scrutiny over ambiguities and potential growth areas for them to bank on. Insights offered in this report will aid the report readers to make fact-based decisions for their businesses in the gas chromatography market.